New Haven, CTNCT07219992Now EnrollingIRB Ready

Anxiety Disorder of Adolescence Clinical Trial in New Haven, CT

Access cutting-edge anxiety disorder of adolescence treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this New Haven location

Preparing your pre-screening questions…

Expert Care in New Haven

Access anxiety disorder of adolescence specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related anxiety disorder of adolescence treatment provided free

Apply for This New Haven Location

Check if you qualify for this anxiety disorder of adolescence clinical trial in New Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Haven site if eligible
  4. 4Begin participation

About This Anxiety Disorder of Adolescence Study in New Haven

This study aims to test the efficacy of a parent-only approach to treating anxiety disorders in adolescents: SPACE (Supportive Parenting for Anxious Childhood Emotions). The comparator is another parent-based approach, PES (Parent Education and Support). The study design is a randomized controlled trial with 2 treatment arms and 3 assessment points (pre, post, and follow-up) using questionnaire data and clinical interviews.

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

Meet criteria for a primary DSM-5 AD, including separation anxiety disorder, social anxiety disorder, generalized anxiety disorder, specific phobia, panic disorder, and agoraphobia (determined by the ADIS-C/P).
Cease all other psychosocial treatment, upon consultation with the project staff and service provider.
Not currently use any psychotropic medication, other than a stable dose (i.e., same dose for a minimum of 6 months prior to enrollment; no changes during course of the study) of a stimulant medication or selective serotonin reuptake inhibitor (SSRI).
Have an eligible and willing participating parent (see parent

Exclusion Criteria

below). Exclusion Criteria: Adolescent:
Meet criteria for any DSM-5 disorder more impairing than the most impairing AD (determined by the ADIS-C/P).
Have any of the following disorders: autism spectrum disorder; intellectual disability; neurocognitive disorders; bipolar disorder; schizophrenia and other psychotic disorders; and alcohol and substance use disorders (determined by the Health History Form and ADIS-C/P).
Report a suicide attempt in the last 3 months, or current suicide intent and plans (determined by the ASQ).
Be a victim of past or present undisclosed abuse requiring investigation or ongoing supervision by the Department of Social Services.
Not have sufficient proficiency with the English language to complete assessments. Parents:
Have any of the following: intellectual disability; neurocognitive disorders; untreated bipolar disorder; untreated schizophrenia and other psychotic disorders; and untreated alcohol and substance use disorders (determined by the Health History Form).
Not be living with the adolescent at least 50% of the time for at least one year prior to enrollment.
Not have sufficient proficiency with the English language to complete assessments and treatment.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Haven?

Yes, this clinical trial (NCT07219992) has an active research site in New Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Anxiety Disorder of Adolescence Treatment Options in New Haven, CT

If you're searching for anxiety disorder of adolescence treatment options in New Haven, CT, this clinical trial (NCT07219992) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced anxiety disorder of adolescence specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all anxiety disorder of adolescence clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in New Haven, CT

See all alzheimers disease clinical trials recruiting in New Haven — not just this study.

Browse Alzheimers Disease Trials in New Haven →

Ready to Join in New Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Haven, CT